ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4,201 | 65.16095 | 1 | male | 0 | 21 | 214 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | null | 0 | 27,118.438 | 18,046.5625 | null | 20.333328 | white | 30.199219 | 44 | 0.710938 | 0.550903 | 1 | 1 | 0 | no | 0.8 | 0.7 | dnr after sadm | 4 | 63 | 7.299805 | 100 | 11 | 36.39844 | 300 | 3 | null | 2.799805 | 130 | 7.439453 | null | null | null | 4 | null | null | 3.183199 |
4,202 | 37.50598 | 1 | male | 1 | 9 | 9 | Coma | Coma | 1 | 12 | $11-$25k | 61 | 69,511.312 | 44,734.5625 | null | 29.5 | white | 20 | 17 | 0.653931 | 0.593994 | 23 | 0 | 0 | no | null | null | dnr after sadm | 2 | 113 | 4.5 | 44 | 6 | 36.89844 | 547.5 | null | null | 0.899902 | 154 | 7.429688 | null | null | null | null | null | <2 mo. follow-up | 2.008789 |
4,203 | 71.56195 | 1 | female | 1 | 43 | 43 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 11 | under $11k | 26 | 171,998.75 | 108,769.625 | null | 38.75 | white | 25.5 | 42 | 0.566895 | 0.455994 | 23 | 1 | 0 | no | 0.5 | 0.4 | dnr after sadm | 27 | 123 | 6.799805 | 120 | 7 | 38.69531 | 450 | 1.799805 | 6.199219 | 0.699951 | 150 | 7.5 | null | null | null | null | null | <2 mo. follow-up | 2.337891 |
4,204 | 71.95599 | 0 | female | 0 | 10 | 1,348 | CHF | COPD/CHF/Cirrhosis | 0 | null | null | 0 | 15,265.047 | 10,070.7109 | null | 20 | black | 26.898438 | 29 | 0.737915 | 0.587891 | 1 | 0 | 0 | no | 0.9 | 0.75 | no dnr | 10 | 75 | 10.398438 | 106 | 26 | 36.79688 | 234.78125 | 2.399902 | 0.799927 | 0.699951 | 141 | 7.389648 | null | null | null | null | null | null | 2.376953 |
4,205 | 63.52399 | 0 | male | 0 | 7 | 1,348 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 5 | under $11k | 0 | 8,887.242 | 6,031.0938 | null | 11.5 | white | 22.898438 | 23 | 0.826904 | 0.768921 | 1 | 0 | 0 | no | null | null | no dnr | 7 | 67 | 17.597656 | 126 | 20 | 35.79688 | 312 | null | 0.699951 | 1 | 139 | 7.459961 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,206 | 45.24597 | 1 | male | 1 | 3 | 3 | Coma | Coma | 0 | 12 | $11-$25k | 89 | 29,102.234 | 18,106.1875 | null | 48 | white | 81.09375 | 80 | 0 | 0 | 3 | 0 | 0 | no | null | null | dnr after sadm | 2 | 0 | 15.099609 | 0 | 0 | 39.19531 | 195 | null | null | 2 | 181 | 7.40918 | null | null | null | null | null | <2 mo. follow-up | 1.310547 |
4,207 | 78.86896 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 26 | 60,337.531 | 35,466.3125 | null | 22 | white | 27.5 | 41 | 0.496948 | 0.379944 | 8 | 0 | 0 | no | null | null | dnr after sadm | 4 | 105 | 16 | 110 | 32 | 38.5 | 197.125 | null | null | 2.699707 | 136 | 7.429688 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,208 | 42.215 | 0 | female | 0 | 110 | 1,345 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 0 | 166,448.625 | 111,714.688 | null | 19.75 | black | 31.796875 | 49 | 0.717896 | 0.631958 | 7 | 0 | 0 | no | null | null | no dnr | 110 | 160 | 29.898438 | 130 | 42 | 38.29688 | 170 | 2.5 | 4.399414 | 0.699951 | 133 | 7.399414 | null | null | null | null | null | adl>=4 (>=5 if sur) | 2.564941 |
4,209 | 33.66699 | 0 | male | 0 | 11 | 1,345 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 9 | under $11k | 0 | 29,377.688 | 20,656.7031 | null | 25 | white | 20.597656 | 32 | 0.893921 | 0.822998 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 11 | 108 | 5.299805 | 74 | 26 | 38.5 | 300 | 2.299805 | 7.399414 | 0.699951 | 136 | 7.419922 | null | null | null | 2 | null | null | 1.839 |
4,210 | 81.53296 | 1 | female | 0 | 11 | 26 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 14 | $11-$25k | 26 | 25,805.188 | 17,326.8438 | null | 24 | white | 20.5 | 33 | 0.724976 | 0.640991 | 1 | 0 | 1 | no | 0.5 | 0.3 | dnr after sadm | 3 | 107 | 10.298828 | 126 | 30 | 38.59375 | 240 | 2.799805 | 0.199982 | 0.799927 | 143 | 7.389648 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
4,211 | 43.88998 | 0 | male | 0 | 14 | 1,345 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 20 | $11-$25k | 0 | 48,116.688 | 31,653.0781 | null | 21.666656 | white | 30.597656 | 37 | 0.75 | 0.670898 | 4 | 0 | 0 | no | 1 | 1 | no dnr | 14 | 100 | 16.699219 | 114 | 25 | 36.59375 | 147.5 | 3 | 0.5 | 1.699951 | 153 | 7.509766 | null | null | null | null | 1 | SIP>=30 | 1 |
4,212 | 69.07599 | 1 | female | 0 | 11 | 269 | CHF | COPD/CHF/Cirrhosis | 3 | 8 | under $11k | 0 | 12,173.898 | 8,183.8711 | null | 17.5 | white | 24.597656 | 25 | 0.78894 | 0.661987 | 1 | 0 | 0 | no | null | null | no dnr | 11 | 49 | 8.898438 | 66 | 24 | 35.59375 | 385.6875 | null | 0.5 | 0.699951 | 138 | 7.40918 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
4,213 | 54.56799 | 1 | male | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 0 | null | 0 | 89,779.188 | 57,363.9688 | null | 45.666657 | black | 40.296875 | 60 | 0.516968 | 0.40094 | 1 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 17 | 56 | 4.099609 | 136 | 14 | 38.09375 | 128 | 2.599609 | 4.299805 | 4.5 | 141 | 7.489258 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,214 | 31.034 | 1 | female | 0 | 14 | 47 | MOSF w/Malig | ARF/MOSF | 1 | 8 | $11-$25k | 55 | 62,115.281 | 39,471.7188 | null | 29.666656 | white | 23.199219 | 44 | 0.424988 | 0.305969 | 17 | 0 | 0 | yes | 0.5 | 0.1 | dnr after sadm | 4 | 110 | 11.599609 | 124 | 32 | 39 | 300 | 1.899902 | 0.399963 | 1.5 | 146 | 7.399414 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
4,215 | 78.78998 | 1 | female | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 15 | $25-$50k | 9 | 53,350.75 | 35,540.5 | null | 31 | white | 39.695313 | 80 | 0.21698 | 0.119995 | 11 | 0 | 0 | no | 0.4 | 0.5 | no dnr | 10 | 115 | 0.799927 | 136 | 32 | 34.79688 | 480 | 2.099609 | 0.699951 | 3.599609 | 138 | 7.479492 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
4,216 | 68.20294 | 1 | male | 0 | 35 | 37 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $25-$50k | 0 | 141,644.125 | 89,196.3125 | null | 31 | white | 31.796875 | 53 | 0.565918 | 0.453979 | 10 | 0 | 0 | no | null | null | no dnr | 35 | 53 | 41.5 | 90 | 15 | 37.59375 | 260 | 2.799805 | 1.099854 | 3.299805 | 127 | 7.509766 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,217 | 21.506 | 0 | female | 0 | 25 | 1,341 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | $11-$25k | 0 | 78,420.438 | 50,620.8125 | null | 36.5 | black | 27 | 33 | 0.879883 | 0.837891 | 2 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 25 | 63 | 25.699219 | 120 | 28 | 38.59375 | 147.5 | 2.799805 | 0.799927 | 0.699951 | 137 | 7.419922 | null | null | null | null | 0 | null | 0 |
4,218 | 52.05197 | 0 | male | 0 | 26 | 1,339 | COPD | COPD/CHF/Cirrhosis | 2 | 15 | $25-$50k | 26 | null | null | null | 29.25 | white | 26.199219 | 36 | 0.799927 | 0.677979 | 1 | 0 | 0 | no | null | null | no dnr | 26 | 150 | 9.298828 | 136 | 24 | 36.09375 | 188 | 3 | 0.199982 | 0.799927 | 143 | 7.389648 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
4,219 | 36.00497 | 1 | female | 0 | 15 | 109 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 17 | null | 0 | 34,299.781 | 22,116.7969 | null | 22 | white | 21.097656 | 34 | 0.882935 | 0.804932 | 1 | 1 | 0 | no | null | null | no dnr | 15 | 63 | 9.398438 | 72 | 10 | 36.39844 | 213.3125 | 2.399902 | 5.099609 | 0.799927 | 133 | 7.439453 | null | null | null | null | 6 | null | 6 |
4,220 | 71.10199 | 1 | male | 0 | 12 | 259 | Lung Cancer | Cancer | 1 | 8 | $25-$50k | 0 | 16,560.844 | 10,550.1875 | null | 10 | white | 25.097656 | 15 | 0.493958 | 0.173981 | 1 | 0 | 0 | metastatic | null | null | no dnr | 12 | 78 | 9.5 | 98 | 20 | 36.89844 | 347.5625 | 2.799805 | 0.5 | 0.599976 | 141 | 7.439453 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,221 | 77.03198 | 1 | female | 1 | 4 | 4 | Coma | Coma | 0 | 11 | under $11k | 61 | 22,531.438 | 13,481.4766 | null | 33 | white | 22.199219 | 23 | 0.334961 | 0.261963 | 1 | 0 | 0 | no | 0.1 | 0.001 | dnr after sadm | 3 | 108 | 11.5 | 106 | 32 | 36.09375 | 414.25 | null | null | 0.899902 | 134 | 7.609375 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,222 | 55.42499 | 1 | male | 0 | 25 | 39 | Cirrhosis | COPD/CHF/Cirrhosis | 1 | 19 | null | 26 | 74,816.188 | 47,502.25 | null | 24.75 | white | 27.199219 | 37 | 0.585938 | 0.393982 | 1 | 0 | 0 | no | null | null | no dnr | 25 | 61 | 10.699219 | 120 | 8 | 35.69531 | 162.5 | 1.5 | 1.799805 | 1.299805 | 135 | 7.419922 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,223 | 53.84299 | 1 | male | 0 | 28 | 244 | CHF | COPD/CHF/Cirrhosis | 1 | 7 | under $11k | 0 | 68,604.688 | 43,377.3125 | null | 27.5 | white | 21.597656 | 22 | 0.875977 | 0.792969 | 1 | 1 | 0 | no | 0.5 | 0.45 | no dnr | 28 | 60 | 9.898438 | 126 | 24 | 38.5 | 273.3125 | 3.099609 | 0.399963 | 0.899902 | 133 | 7.389648 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
4,224 | 44.89499 | 0 | male | 0 | 9 | 1,335 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | null | 0 | 35,564.938 | 22,103.875 | null | 24.5 | black | 30.699219 | 48 | 0.778931 | 0.707886 | 1 | 0 | 0 | no | null | null | no dnr | 9 | 72 | 11.298828 | 58 | 28 | 38.69531 | 102.5 | 3 | 0.199982 | 3 | 141 | 7.399414 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,225 | 72.34198 | 1 | male | 0 | 4 | 125 | Lung Cancer | Cancer | 2 | 8 | null | 0 | 4,382.75 | 2,688.4356 | null | 9 | white | 18.796875 | 18 | 0.651978 | 0.345947 | 1 | 1 | 0 | metastatic | 0.9 | 0.7 | no dnr | 4 | 109 | 11.898438 | 76 | 16 | 36.79688 | null | 3.099609 | 0.299988 | 0.899902 | 140 | null | null | null | null | null | null | no(M2 and SIP pres) | 2.300781 |
4,226 | 58.491 | 1 | male | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 9 | 19,705.547 | 12,076.5703 | null | 51 | black | 35.296875 | 63 | 0.584961 | 0.475952 | 1 | 1 | 0 | no | null | null | dnr after sadm | 5 | 61 | 14.199219 | 134 | 44 | 37.69531 | 122 | 3 | 0.899902 | 2.699707 | 135 | 7.279297 | null | null | null | null | null | <2 mo. follow-up | 2.405762 |
4,227 | 61.91898 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 5 | under $11k | 37 | 53,453.531 | 32,532.9219 | null | 42.5 | white | 32.59375 | 48 | 0.440979 | 0.32196 | 4 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 6 | 59 | 3.5 | 106 | 10 | 36.29688 | 197.5 | 3.399902 | 1.899902 | 7 | 133 | 7.25 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,228 | 91.20898 | 1 | male | 0 | 28 | 63 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | $25-$50k | 37 | 175,216.125 | 115,518 | null | 24.75 | white | 26.898438 | 49 | 0.335999 | 0.219971 | 24 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 28 | 74 | 11.898438 | 70 | 32 | 37.69531 | 222.84375 | 3.299805 | 11 | 1.5 | 154 | 7.429688 | null | null | null | null | null | null | 3.289063 |
4,229 | 64.97998 | 1 | female | 1 | 24 | 24 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | under $11k | 37 | 80,000.812 | 53,980 | null | 38.666657 | white | 38.09375 | 60 | 0.31897 | 0.204987 | 1 | 1 | 0 | no | 0.3 | 0.2 | dnr after sadm | 23 | 115 | 19.699219 | 134 | 26 | 37.89844 | 115.54688 | 1.399902 | 1.699951 | 2.899902 | 129 | 7.399414 | null | null | null | null | null | <2 mo. follow-up | 2.566406 |
4,230 | 72.24097 | 1 | male | 0 | 24 | 60 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 0 | null | 0 | 143,222.5 | 87,619.625 | null | 46.333313 | white | 32.5 | 46 | 0.495972 | 0.377991 | 26 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 24 | 121 | 4.399414 | 134 | 29 | 36.5 | 193.3125 | null | null | 2.699707 | 137 | 7.399414 | null | null | null | null | null | null | 2.198731 |
4,231 | 75.67395 | 1 | female | 1 | 23 | 23 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 14 | $11-$25k | 9 | 171,279.125 | 106,489.75 | null | 49 | white | 33.898438 | 61 | 0.40094 | 0.281982 | 14 | 1 | 0 | no | null | null | dnr after sadm | 23 | 60 | 22.5 | 136 | 9 | 35.89844 | 202.5 | 2.399902 | 3.099609 | 2 | 152 | 7.40918 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,232 | 25.56899 | 0 | female | 0 | 38 | 1,331 | Coma | Coma | 0 | 17 | $11-$25k | 44 | 85,945.312 | 57,810.7188 | null | 22.25 | white | 24.796875 | 19 | 0.781982 | 0.73999 | 1 | 0 | 0 | no | null | null | no dnr | 38 | 73 | 6.899414 | 40 | 8 | 35 | 519 | 3.799805 | 1.5 | 0.599976 | 142 | 7.519531 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
4,233 | 58.81198 | 1 | male | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 9 | 54,651.594 | 33,309.8125 | null | 42.5 | black | 33.09375 | 53 | 0.54895 | 0.434998 | 10 | 1 | 0 | no | 0.4 | 0.1 | dnr after sadm | 11 | 76 | 12.599609 | 130 | 30 | 36.19531 | 187.5 | 2.299805 | null | 3.199707 | 134 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,234 | 66.92395 | 1 | male | 0 | 7 | 183 | Colon Cancer | Cancer | 1 | 15 | $11-$25k | 0 | 7,351.648 | 4,601.1953 | null | 10.5 | white | 14 | 15 | 0.850952 | 0.670898 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 7 | 107 | 5.399414 | 64 | 20 | 37.09375 | null | null | 0.799927 | 1 | 141 | null | null | null | null | null | 0 | null | 0 |
4,235 | 78.78699 | 1 | male | 1 | 74 | 74 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | null | 41 | null | null | null | 37.5 | white | 30.199219 | 59 | 0.323975 | 0.209991 | 12 | 0 | 0 | no | 0.5 | 0.4 | no dnr | 74 | 83 | 25.097656 | 120 | 4 | 38.39844 | 157.5 | 2.399902 | 1.199951 | 1.699951 | 137 | 7.30957 | null | null | null | null | 0 | null | 0 |
4,236 | 27.661 | 0 | male | 0 | 7 | 1,327 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 22,497.688 | 14,607.8906 | null | 12 | black | 19 | 14 | 0.92395 | 0.896973 | 3 | 0 | 0 | no | 1 | 1 | no dnr | 7 | 110 | 14.398438 | 100 | 22 | 36.29688 | 260 | 2.5 | null | 0.899902 | 138 | 7.449219 | null | null | null | null | null | null | 2.190918 |
4,237 | 58.823 | 1 | male | 1 | 23 | 23 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 0 | 109,539.875 | 70,529.375 | null | 44 | white | 25.5 | 40 | 0.746948 | 0.666992 | 13 | 1 | 0 | no | 0.6 | 0.5 | dnr after sadm | 16 | 117 | 12.798828 | 110 | 13 | 36.39844 | 180 | 1.199951 | 0.799927 | 0.899902 | 133 | 7.419922 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
4,238 | 73.37994 | 1 | female | 0 | 45 | 676 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 41 | null | null | null | 16.5 | black | 21.699219 | 33 | 0.592896 | 0.484985 | 17 | 0 | 0 | no | 0.8 | 0.85 | no dnr | 45 | 124 | 6.299805 | 116 | 28 | 37.79688 | 204 | null | null | 0.899902 | 144 | 7.439453 | null | null | null | null | 0 | null | 0 |
4,239 | 54.431 | 1 | female | 0 | 4 | 261 | Colon Cancer | Cancer | 1 | null | null | 0 | 2,386.049 | 1,735.0772 | null | 13 | white | 24.199219 | 12 | 0.723999 | 0.448975 | 1 | 0 | 0 | metastatic | null | null | no dnr | 4 | 76 | 5 | 104 | 20 | 39 | null | 2.799805 | null | 0.899902 | 137 | null | null | null | null | null | null | null | 1.887451 |
4,240 | 70.12195 | 1 | female | 1 | 24 | 24 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 37 | 92,355.25 | 54,605 | null | 53 | black | 27.5 | 32 | 0.543945 | 0.429993 | 3 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 22 | 56 | 14.199219 | 124 | 10 | 35.69531 | 237.125 | null | 0.099991 | 1.199951 | 154 | 7.529297 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,241 | 76.20496 | 1 | male | 1 | 11 | 11 | MOSF w/Malig | ARF/MOSF | 2 | 12 | $11-$25k | 41 | 38,628.625 | 24,617.3281 | null | 40.5 | white | 36.296875 | 90 | 0.075989 | 0.028 | 2 | 0 | 0 | metastatic | 0.1 | 0.001 | dnr before sadm | 0 | 59 | 0.099991 | 136 | 28 | 36.39844 | 250 | 1.899902 | 2.199707 | 2.099609 | 143 | 7.429688 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
4,242 | 80.71198 | 0 | female | 0 | 34 | 1,324 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 61 | 61,520.188 | 41,577.7188 | null | 24.25 | white | 15.199219 | 13 | 0.666992 | 0.570923 | 4 | 0 | 0 | no | 0.25 | 0.1 | no dnr | 34 | 75 | 9.599609 | 66 | 9 | 37.5 | 225.6875 | 2.599609 | null | 0.699951 | 141 | 7.479492 | null | null | null | null | 3 | adl>=4 (>=5 if sur) | 3 |
4,243 | 47.918 | 1 | male | 0 | 5 | 37 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 10 | under $11k | 0 | 3,757 | 2,664.832 | null | 4 | black | 26.796875 | 48 | 0.75293 | 0.609985 | 1 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 5 | 118 | 15.599609 | 91 | 44 | 37.89844 | null | 2.399902 | 22 | 1.099854 | 136 | null | null | null | null | 0 | 0 | <2 mo. follow-up | 0 |
4,244 | 68.32599 | 1 | male | 0 | 7 | 57 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 20,914.094 | 14,036.7734 | null | 17.5 | white | 31.5 | 41 | 0.598999 | 0.409973 | 6 | 1 | 0 | no | 0.7 | 0.3 | no dnr | 7 | 46 | 12.199219 | 60 | 32 | 36.39844 | 338.0625 | null | null | 1 | 128 | 7.519531 | null | null | null | 1 | 0 | <2 mo. follow-up | 0 |
4,245 | 58.03699 | 1 | male | 1 | 16 | 16 | Coma | Coma | 1 | null | null | 100 | null | null | null | 24 | white | 23.296875 | 43 | 0.294983 | 0.223999 | 1 | 0 | 0 | no | null | null | dnr after sadm | 4 | 109 | 14.298828 | 130 | 28 | 39 | 270 | 1.799805 | 0.799927 | 1.699951 | 141 | 7.349609 | null | null | null | null | null | <2 mo. follow-up | 2.536133 |
4,246 | 54.63098 | 0 | female | 0 | 113 | 1,321 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 7 | under $11k | 0 | null | null | null | 38.75 | white | 24 | 27 | 0.784912 | 0.713989 | 16 | 0 | 0 | no | 0.4 | 0.4 | no dnr | 113 | 99 | 23.5 | 184 | 14 | 38.5 | 236.65625 | null | 0.799927 | 0.399963 | 135 | 7.449219 | null | null | null | null | 7 | null | 7 |
4,247 | 54.40399 | 0 | female | 0 | 31 | 1,320 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 41 | 77,659.062 | 52,406.4375 | null | 29.5 | white | 26.898438 | 50 | 0.672974 | 0.576904 | 1 | 1 | 0 | no | null | null | no dnr | 31 | 69 | 5.799805 | 106 | 23 | 38.59375 | 113.84375 | 1.599854 | 0.899902 | 1.699951 | 142 | 7.55957 | null | null | null | null | null | null | 2.958008 |
4,248 | 70.43695 | 1 | female | 1 | 21 | 21 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 196,870.625 | 117,628.062 | null | 52 | white | 41.5 | 71 | 0.265991 | 0.159973 | 11 | 0 | 0 | no | null | null | dnr after sadm | 19 | 59 | 46.5 | 138 | 30 | 35.89844 | 272.5 | null | 5.199219 | 4.399414 | 127 | 7.359375 | null | null | null | null | null | <2 mo. follow-up | 2.1875 |
4,249 | 68.85095 | 1 | male | 0 | 16 | 220 | Colon Cancer | Cancer | 1 | null | null | 0 | 18,922.438 | 12,394.3828 | null | 16.666656 | white | 28.597656 | 50 | 0.580933 | 0.260986 | 1 | 0 | 0 | metastatic | null | null | no dnr | 16 | 133 | 13.699219 | 128 | 36 | 39.29688 | 276 | null | 6.099609 | 0.899902 | 134 | 7.489258 | null | null | null | null | null | null | 2.616211 |
4,250 | 54.08899 | 0 | female | 0 | 57 | 1,319 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 6 | null | 37 | 121,103.375 | 80,398.8125 | null | 25.5 | black | 21.398438 | 41 | 0.787964 | 0.718994 | 1 | 0 | 0 | no | null | null | no dnr | 57 | 113 | 7.5 | 110 | 30 | 38.19531 | 368 | 2.799805 | 0.5 | 2.299805 | 144 | 7.469727 | null | null | null | null | 6 | null | 6 |
4,251 | 66.349 | 0 | male | 0 | 9 | 1,320 | COPD | COPD/CHF/Cirrhosis | 3 | 14 | under $11k | 0 | 13,372.742 | 9,138.5938 | null | 21.5 | black | 31.199219 | 36 | 0.684937 | 0.517944 | 1 | 0 | 0 | no | null | null | no dnr | 9 | 127 | 14.699219 | 126 | 6 | 36.29688 | 182.84375 | 2.399902 | 0.5 | 1.399902 | 139 | 7.379883 | null | null | null | 1 | null | SIP>=30 | 1.1669 |
4,252 | 60.89297 | 1 | female | 0 | 9 | 11 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | null | 0 | 15,443.594 | 11,158.2109 | null | 14 | white | 19 | 16 | 0.882935 | 0.803955 | 1 | 0 | 0 | no | 0.8 | 0.6 | no dnr | 9 | 103 | 13.898438 | 64 | 24 | 35.59375 | 252 | null | null | 1.199951 | 137 | 7.449219 | null | null | null | 2 | null | <2 mo. follow-up | 1.839 |
4,253 | 44.89798 | 1 | male | 1 | 5 | 5 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 26 | 26,682.391 | 18,153.2812 | null | 42 | white | 39.09375 | 85 | 0.360962 | 0.168976 | 1 | 0 | 0 | no | null | null | no dnr | 5 | 45 | 5.599609 | 174 | 36 | 38.19531 | 206 | 2.199707 | 11.699219 | 1.199951 | 132 | 7.55957 | null | null | null | null | 3 | <2 mo. follow-up | 3 |
4,254 | 69.20197 | 1 | female | 0 | 10 | 41 | Lung Cancer | Cancer | 1 | null | null | 0 | 6,285.047 | 4,821.9883 | null | 7 | white | 18.898438 | 9 | 0.657959 | 0.35498 | 1 | 0 | 0 | metastatic | null | null | no dnr | 10 | 93 | 9.298828 | 100 | 16 | 35.39844 | null | null | 0.5 | 0.899902 | 138 | null | null | null | null | null | null | <2 mo. follow-up | 2.80957 |
4,255 | 56.06299 | 0 | female | 0 | 5 | 1,317 | CHF | COPD/CHF/Cirrhosis | 5 | 12 | null | 0 | 8,491.492 | 5,716.0938 | null | 9 | black | 19.5 | 25 | 0.888916 | 0.813965 | 1 | 1 | 0 | no | 0.7 | 0.5 | no dnr | 5 | 73 | 9.699219 | 52 | 24 | 36.79688 | 376.1875 | null | null | 1.699951 | 136 | 7.419922 | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,256 | 75.14294 | 1 | male | 0 | 54 | 595 | MOSF w/Malig | ARF/MOSF | 1 | 8 | null | 0 | 218,304.75 | 141,797.875 | null | 37.25 | white | 32.796875 | 57 | 0.339966 | 0.223999 | 17 | 0 | 0 | yes | null | null | no dnr | 54 | 133 | 0.299988 | 134 | 24 | 39 | 231.40625 | 2.399902 | 4.399414 | 1 | 152 | 7.429688 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
4,257 | 77.42596 | 1 | male | 0 | 21 | 697 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | $11-$25k | 0 | 42,596.344 | 28,186.9375 | null | 26.333328 | white | 33.796875 | 66 | 0.545898 | 0.432983 | 1 | 1 | 0 | no | 0.75 | 0.6 | no dnr | 21 | 63 | 15.798828 | 60 | 0 | 34.89844 | 343.3125 | 2.5 | null | 5.5 | 131 | 7.5 | null | null | null | null | 1 | no(M2 and SIP pres) | 1 |
4,258 | 64.51196 | 1 | female | 0 | 6 | 1,292 | Colon Cancer | Cancer | 1 | 15 | $11-$25k | 0 | 8,172.75 | 4,955.9102 | null | 16 | white | 15.898438 | 13 | 0.831909 | 0.633911 | 1 | 0 | 0 | metastatic | null | null | no dnr | 6 | 104 | 4.5 | 76 | 20 | 36.19531 | null | 3.399902 | 0.399963 | 0.799927 | 142 | null | null | null | null | 0 | 0 | no(M2 and SIP pres) | 0 |
4,259 | 57.57199 | 1 | male | 0 | 6 | 284 | CHF | COPD/CHF/Cirrhosis | 1 | 16 | null | 0 | 3,218.248 | 2,497.7969 | null | 12 | hispanic | 21.699219 | 28 | 0.86499 | 0.776978 | 1 | 0 | 0 | no | null | null | no dnr | 6 | 110 | 8.099609 | 96 | 24 | 36.79688 | null | null | null | 3 | 144 | null | null | null | null | 1 | null | null | 1.1669 |
4,260 | 82.52698 | 1 | male | 1 | 7 | 7 | CHF | COPD/CHF/Cirrhosis | 1 | 5 | under $11k | 26 | 27,246.438 | 16,079.7734 | null | 37.5 | black | 53.796875 | 68 | 0.007 | 0 | 1 | 0 | 0 | no | null | null | dnr after sadm | 7 | 39 | 15.898438 | 134 | 20 | 36.69531 | 108.75 | 2.799805 | 0.399963 | 3.799805 | 132 | 7.319336 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
4,261 | 64.961 | 1 | female | 0 | 42 | 564 | MOSF w/Malig | ARF/MOSF | 0 | 11 | under $11k | 37 | null | null | null | 14.5 | black | 22 | 43 | 0.55188 | 0.438965 | 3 | 0 | 0 | yes | 0.75 | 0.5 | no dnr | 42 | 137 | null | 106 | 30 | 38.5 | 350 | 2 | null | 2 | 132 | 7.469727 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
4,262 | 90.71594 | 1 | female | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 18 | null | 9 | 21,404.297 | 13,206.875 | null | 26 | black | 35.695313 | 54 | 0.306946 | 0.19397 | 3 | 0 | 0 | no | 0.25 | 0.2 | dnr after sadm | 5 | 108 | 12 | 100 | 36 | 35.19531 | 91.82812 | null | null | 1.899902 | 135 | 7.439453 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,263 | 69.21594 | 1 | female | 0 | 34 | 55 | MOSF w/Malig | ARF/MOSF | 2 | 9 | under $11k | 0 | 86,351.562 | 55,435.9688 | null | 40 | white | 31.5 | 70 | 0.481995 | 0.363953 | 2 | 1 | 0 | yes | null | null | no dnr | 34 | 67 | 1.099854 | 170 | 32 | 35.79688 | 336.625 | 1.799805 | 0.599976 | 1.299805 | 147 | 7.299805 | null | null | null | null | 1 | <2 mo. follow-up | 1 |
4,264 | 56.37198 | 1 | male | 1 | 13 | 13 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 17 | null | 0 | 42,452.438 | 27,247.7812 | null | 41.5 | white | 29.898438 | 59 | 0.668945 | 0.572998 | 2 | 0 | 0 | yes | null | null | dnr after sadm | 6 | 56 | 16.699219 | 140 | 12 | 39.89844 | 240 | 1.799805 | 3.199707 | 1.899902 | 143 | 7.359375 | null | null | null | null | null | <2 mo. follow-up | 2.12207 |
4,265 | 44.67398 | 1 | female | 0 | 5 | 134 | Colon Cancer | Cancer | 3 | 12 | $11-$25k | 0 | 2,538.799 | 1,843.1514 | null | 9 | white | 15.398438 | 14 | 0.86792 | 0.702881 | 1 | 1 | 0 | metastatic | null | null | no dnr | 5 | 73 | 4.799805 | 80 | 20 | 36.59375 | null | null | 0.5 | 0.599976 | 136 | null | null | null | null | null | null | no(M2 and SIP pres) | 1.945557 |
4,266 | 26.752 | 0 | male | 0 | 14 | 1,310 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 10 | null | 0 | 35,316.125 | 23,421.3906 | null | 23 | black | 36.398438 | 46 | 0.756958 | 0.679932 | 1 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 14 | 51 | 21.699219 | 130 | 12 | 39.39844 | 108 | 2.199707 | 1.699951 | 1 | 137 | 7.349609 | null | null | null | null | 0 | null | 0 |
4,267 | 23.26399 | 0 | male | 0 | 22 | 1,309 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | null | 9 | 93,008.875 | 58,490.0625 | null | 36.666657 | black | 25.5 | 34 | 0.86499 | 0.817993 | 4 | 0 | 0 | no | null | null | no dnr | 22 | 110 | 20.199219 | 110 | 38 | 38.69531 | 150 | 2.099609 | 0.899902 | 0.899902 | 143 | 7.449219 | null | null | null | null | 0 | no(M2 and SIP pres) | 0 |
4,268 | 88.172 | 1 | male | 1 | 7 | 7 | Coma | Coma | 1 | null | null | 55 | 17,919.734 | 12,661.3359 | null | 15 | white | 17.898438 | 17 | 0.378967 | 0.304993 | 1 | 0 | 0 | no | null | null | dnr after sadm | 3 | 89 | 14.699219 | 54 | 14 | 37.09375 | 433.3125 | null | null | 1.099854 | 135 | 7.55957 | null | null | null | null | 4 | <2 mo. follow-up | 4 |
4,269 | 49.711 | 0 | female | 0 | 14 | 1,309 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 8 | null | 0 | 49,613.438 | 31,112.6875 | null | 23 | white | 27.199219 | 29 | 0.751953 | 0.67395 | 15 | 0 | 0 | no | 0.9 | 0.88 | no dnr | 14 | 82 | 8.898438 | 112 | 42 | 37.59375 | 180 | null | null | 0.5 | 131 | 7.5 | null | null | null | null | 2 | no(M2 and SIP pres) | 2 |
4,270 | 66.02295 | 1 | female | 1 | 11 | 11 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 10 | under $11k | 0 | 68,266.188 | 41,666.3125 | null | 50 | white | 25.898438 | 39 | 0.747925 | 0.668945 | 3 | 0 | 0 | no | 0.4 | 0.35 | dnr after sadm | 10 | 61 | 8 | 120 | 40 | 39.19531 | 147.25 | null | null | 0.799927 | 135 | 7.449219 | null | null | null | null | 0 | <2 mo. follow-up | 0 |
4,271 | 73.86694 | 1 | female | 0 | 38 | 145 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 11 | under $11k | 44 | 139,384.25 | 91,699.9375 | null | 24.5 | white | 17.898438 | 16 | 0.672974 | 0.577881 | 13 | 0 | 0 | no | null | null | dnr after sadm | 21 | 63 | 9.099609 | 100 | 11 | 37.39844 | 336 | 3 | null | 0.5 | 140 | 7.479492 | null | null | null | null | 0 | adl>=4 (>=5 if sur) | 0 |
4,272 | 76.97998 | 1 | male | 1 | 16 | 16 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | null | null | 0 | 58,267.438 | 38,300.0938 | null | 36.333313 | white | 39.296875 | 69 | 0.302979 | 0.190979 | 1 | 0 | 0 | yes | 0.6 | 0.55 | dnr after sadm | 11 | 45 | 4.299805 | 74 | 14 | 37.89844 | 92 | 1.5 | 0.399963 | 2.599609 | 148 | 7.199219 | null | null | null | null | null | <2 mo. follow-up | 3.002441 |
4,273 | 58.92999 | 0 | female | 0 | 79 | 1,307 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 37 | 128,515.375 | 85,647.1875 | null | 16.5 | white | 25.398438 | 51 | 0.642944 | 0.541992 | 5 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 79 | 137 | 16.898438 | 160 | 29 | 39 | 360 | 1.599854 | 0.699951 | 0.399963 | 136 | 7.459961 | null | null | null | null | 1 | adl>=4 (>=5 if sur) | 1 |
4,274 | 38.74597 | 0 | female | 0 | 20 | 1,307 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $11-$25k | 0 | 132,709.625 | 93,150.0625 | null | 15 | white | 25.5 | 37 | 0.807983 | 0.743896 | 39 | 1 | 0 | no | 0.5 | 0.5 | no dnr | 20 | 109 | 1.699951 | 66 | 22 | 36.29688 | 290 | 1.599854 | 0.699951 | 1.899902 | 136 | 7.419922 | null | null | null | 0 | 0 | null | 0 |
4,275 | 29.62099 | 1 | female | 0 | 15 | 19 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | >$50k | 89 | 53,349.375 | 34,999 | null | 34.666657 | white | 39.695313 | 35 | 0.17099 | 0.08699 | 1 | 0 | 0 | yes | 0.5 | 0.4 | no dnr | 15 | 75 | 2.699707 | 50 | 29 | 35.29688 | 256 | 2.699707 | 0.599976 | 0.5 | 118 | 7.449219 | null | null | null | null | 7 | <2 mo. follow-up | 7 |
4,276 | 64.54199 | 1 | female | 0 | 31 | 100 | COPD | COPD/CHF/Cirrhosis | 2 | null | null | 0 | 213,444.5 | 144,919 | null | 17.5 | white | 22.699219 | 28 | 0.766968 | 0.629883 | 59 | 0 | 0 | no | null | null | no dnr | 31 | 112 | 7.599609 | 124 | 40 | 38 | 233.3125 | null | null | 0.5 | 139 | 7.40918 | null | null | null | null | null | null | 2.526367 |
4,277 | 77.40698 | 1 | male | 1 | 7 | 7 | Cirrhosis | COPD/CHF/Cirrhosis | 2 | 12 | null | 37 | 37,871.438 | 24,670.9062 | null | 23 | white | 43.398438 | 102 | 0 | 0 | 14 | 1 | 0 | metastatic | null | null | dnr after sadm | 6 | 51 | 4.599609 | 104 | 26 | 34.29688 | 176 | 1.399902 | 5.799805 | 4.5 | 137 | 7.329102 | null | null | null | null | 6 | <2 mo. follow-up | 6 |
4,278 | 55.491 | 0 | female | 0 | 33 | 1,301 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 15 | $25-$50k | 0 | 98,300.812 | 64,919.1562 | null | 26 | white | 21.199219 | 30 | 0.849976 | 0.797974 | 3 | 0 | 0 | no | null | null | no dnr | 33 | 111 | 6.899414 | 110 | 40 | 38.29688 | 373.3125 | 2.399902 | null | 0.5 | 141 | 7.349609 | null | null | null | null | 0 | SIP>=30 | 0 |
4,279 | 74.96497 | 1 | female | 1 | 12 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 35,012.969 | 22,773.625 | null | 38.5 | white | 27.398438 | 56 | 0.651978 | 0.552979 | 6 | 0 | 0 | no | 0.3 | 0.3 | no dnr | 12 | 67 | 16.398438 | 150 | 48 | 36.29688 | 223.3125 | 2.299805 | 1.099854 | 1.599854 | 135 | 7.40918 | null | null | null | null | 5 | <2 mo. follow-up | 5 |
4,280 | 65.41498 | 1 | female | 0 | 14 | 803 | COPD | COPD/CHF/Cirrhosis | 2 | 14 | under $11k | 0 | 14,174 | null | null | 9.333328 | white | 20.199219 | 29 | 0.825928 | 0.716919 | 1 | 0 | 0 | yes | 0.8 | 0.8 | dnr before sadm | 0 | 80 | 8.699219 | 80 | 25 | 37.79688 | 201.65625 | 3.899902 | 0.799927 | 2.299805 | 139 | 7.319336 | 337 | 41 | 3,800 | 0 | 0 | no(M2 and SIP pres) | 0 |
4,281 | 44.909 | 1 | male | 1 | 24 | 24 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | null | 26 | 55,018 | null | null | 17.333328 | white | 43.398438 | 59 | 0.311951 | 0.198975 | 3 | 0 | 0 | no | 0.75 | 0.7 | dnr after sadm | 24 | 46 | 10.898438 | 122 | 33 | 36.09375 | null | 2.599609 | 1 | 1.299805 | 144 | null | 94 | 20 | 4,950 | null | 0 | <2 mo. follow-up | 0 |
4,282 | 65.31396 | 1 | female | 0 | 40 | 129 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 57,653 | null | null | 23.25 | white | 26.398438 | 46 | 0.768921 | 0.694946 | 1 | 0 | 0 | no | 0.75 | 0.6 | no dnr | 40 | 73 | 7.399414 | 138 | 32 | 38.89844 | 400 | null | 0.699951 | 0.699951 | 138 | 7.419922 | 88 | 4 | 1,600 | null | 1 | null | 1 |
4,283 | 50.396 | 0 | female | 0 | 35 | 1,086 | Coma | Coma | 1 | 12 | $25-$50k | 44 | 90,395 | null | null | 24.75 | white | 26.296875 | 38 | 0.544922 | 0.475952 | 2 | 1 | 0 | no | 0.05 | 0.05 | dnr after sadm | 3 | 73 | 6.799805 | 54 | 22 | 36.69531 | null | 2.5 | 2.399902 | 0.599976 | 137 | null | 66 | 9 | 1,100 | null | 0 | no(M2 and SIP pres) | 0 |
4,284 | 39.26898 | 1 | female | 1 | 7 | 7 | MOSF w/Malig | ARF/MOSF | 1 | 13 | $25-$50k | 9 | 75,303 | 47,321.2812 | 45,979 | 29 | white | 36.59375 | 83 | 0.169983 | 0.085999 | 20 | 0 | 0 | metastatic | 0.5 | 0 | dnr after sadm | 2 | 73 | 5.599609 | 80 | 25 | 37.79688 | 247.59375 | 3.599609 | 0.699951 | 2.5 | 138 | 7.489258 | 104 | 53 | null | null | 1 | <2 mo. follow-up | 1 |
4,285 | 69.13599 | 1 | female | 1 | 3 | 3 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | $25-$50k | 0 | 18,689 | null | null | 46 | white | 75.296875 | 87 | 0 | 0 | 1 | 1 | 0 | no | 0.1 | 0.5 | no dnr | 3 | 73 | 23.597656 | 108 | 26 | 36.19531 | 410.6875 | 3.099609 | null | 1.199951 | 141 | 7.359375 | 291 | 38 | 1,605 | null | 2 | <2 mo. follow-up | 2 |
4,286 | 40.34998 | 1 | female | 0 | 4 | 70 | CHF | COPD/CHF/Cirrhosis | 1 | 13 | null | 0 | 2,466 | null | null | 8 | black | 22.699219 | 36 | 0.897949 | 0.828979 | 1 | 0 | 0 | no | 0.4 | 0.05 | dnr after sadm | 1 | 110 | 5.5 | 60 | 20 | 36.09375 | 276.1875 | null | null | 1.099854 | 137 | 7.349609 | 152 | 23 | 550 | 6 | null | adl>=4 (>=5 if sur) | 4.527344 |
4,287 | 67.87695 | 1 | male | 0 | 17 | 767 | Colon Cancer | Cancer | 1 | 12 | null | 0 | 32,329 | null | null | 19.333328 | white | 41.398438 | 33 | 0.218994 | 0.022999 | 1 | 0 | 0 | metastatic | 0.93 | 0.8 | no dnr | 17 | 67 | null | 60 | 25 | 38.29688 | 370.3125 | 2.599609 | null | 1.599854 | 142 | 7.419922 | 278 | 24 | 1,300 | null | 1 | null | 1 |
4,288 | 76.71997 | 1 | female | 0 | 8 | 736 | Lung Cancer | Cancer | 2 | 18 | $11-$25k | 0 | 11,391 | null | null | 15.5 | white | 22.796875 | 14 | 0.537964 | 0.214996 | 1 | 1 | 0 | metastatic | 0.8 | 0.6 | no dnr | 8 | 77 | 21.296875 | 80 | 20 | 36.09375 | 300 | null | 1.299805 | 0.899902 | 140 | 7.429688 | 136 | 11 | null | 3 | 1 | null | 1 |
4,289 | 47.52399 | 0 | male | 0 | 93 | 1,082 | Coma | Coma | 0 | 14 | null | 89 | 154,483 | 100,133.438 | 94,355 | 26.75 | white | 18.796875 | 16 | 0.541992 | 0.472961 | 3 | 0 | 0 | no | 0.8 | 0.75 | dnr after sadm | 42 | 56 | 5.099609 | 102 | 40 | 38.29688 | 330 | 2.899902 | null | 1.099854 | 136 | 7.479492 | 108 | 16 | 5,380 | null | 0 | adl>=4 (>=5 if sur) | 0 |
4,290 | 80.68994 | 1 | female | 1 | 4 | 4 | Coma | Coma | 2 | 6 | $11-$25k | 100 | 67,555 | null | null | 40 | white | 21.296875 | 37 | 0.064987 | 0.035995 | 15 | 1 | 0 | no | 0.05 | 0.05 | dnr after sadm | 3 | 107 | 7.399414 | 68 | 20 | 36.39844 | null | null | null | 0.799927 | 135 | null | 93 | 12 | null | null | null | <2 mo. follow-up | 3.039551 |
4,291 | 46.39297 | 1 | male | 0 | 29 | 60 | MOSF w/Malig | ARF/MOSF | 0 | null | null | 0 | 46,628 | null | null | 20.75 | white | 16.699219 | 17 | 0.835938 | 0.779907 | 1 | 0 | 0 | yes | 0.8 | 0.5 | no dnr | 29 | 52 | 12.298828 | 107 | 8 | 35.59375 | 135 | null | 0.5 | 2.899902 | 142 | 7.319336 | 99 | 65 | 2,095 | null | null | null | 1.986816 |
4,292 | 68.96899 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | null | 0 | 46,514 | null | null | 50 | white | 53.898438 | 98 | 0.022999 | 0.004999 | 31 | 0 | 0 | no | 0.1 | 0.1 | no dnr | 4 | 107 | 9.599609 | 76 | 16 | 37.09375 | null | null | 0.5 | 1.099854 | 144 | null | 63 | 17 | null | null | 2 | <2 mo. follow-up | 2 |
4,293 | 67.67395 | 1 | male | 1 | 35 | 35 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | >$50k | 37 | 162,435 | null | null | 37.75 | hispanic | 30.296875 | 72 | 0.41394 | 0.293945 | 15 | 0 | 0 | no | 0.2 | 0.2 | dnr after sadm | 35 | 70 | 5.899414 | 80 | 20 | 35.59375 | 400 | null | null | 2.099609 | 143 | 7.5 | 139 | 24 | null | null | 0 | <2 mo. follow-up | 0 |
4,294 | 58.22897 | 1 | male | 0 | 6 | 195 | Colon Cancer | Cancer | 1 | 16 | >$50k | 0 | 10,123 | null | null | 9 | white | 13.699219 | 6 | 0.866943 | 0.701904 | 1 | 0 | 0 | metastatic | 0.9 | 0.6 | no dnr | 6 | 119 | 16.398438 | 102 | 28 | 35.59375 | 113.32812 | 2.5 | 0.299988 | 0.699951 | 137 | 7.509766 | 72 | 13 | 3,265 | 1 | 1 | no(M2 and SIP pres) | 1 |
4,295 | 55.99698 | 1 | male | 0 | 78 | 183 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 0 | 325,893 | null | null | 39 | white | 38.695313 | 54 | 0.441956 | 0.322998 | 15 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 78 | 77 | 6.799805 | 70 | 20 | 36.09375 | null | 3.699707 | 2.099609 | 2.299805 | 138 | null | 120 | 35 | null | null | null | Coma or Intub | 2.189453 |
4,296 | 59.38397 | 0 | male | 0 | 41 | 1,078 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 8 | under $11k | 0 | 92,841 | 64,880.2812 | 57,448 | 22.75 | white | 28.898438 | 47 | 0.704956 | 0.615967 | 5 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 41 | 37 | 0.399963 | 188 | 10 | 36.09375 | 140 | 2.299805 | 1.299805 | 1 | 143 | 7.459961 | 150 | 31 | 2,235 | null | 1 | adl>=4 (>=5 if sur) | 1 |
4,297 | 34.853 | 0 | female | 0 | 29 | 1,077 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | $25-$50k | 0 | 67,010 | null | null | 21 | white | 26.699219 | 24 | 0.850952 | 0.799927 | 2 | 0 | 0 | no | 0.7 | 0.7 | no dnr | 29 | 69 | 0.699951 | 77 | 32 | 39.39844 | 170 | 2.799805 | 2.099609 | 2.799805 | 134 | 7.469727 | 118 | 46 | 3,410 | null | 7 | no(M2 and SIP pres) | 7 |
4,298 | 68.39996 | 0 | male | 0 | 17 | 1,076 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 0 | 45,859 | null | null | 13.666664 | white | 16.597656 | 7 | 0.851929 | 0.800903 | 7 | 0 | 0 | no | 0.75 | 0.5 | dnr after sadm | 2 | 63 | 6.299805 | 110 | 6 | 39.89844 | 312.5 | null | null | 1.399902 | 132 | 7.329102 | 165 | 10 | 6,990 | null | 0 | adl>=4 (>=5 if sur) | 0 |
4,299 | 54.84198 | 0 | male | 0 | 10 | 1,076 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 15 | $11-$25k | 0 | 30,104 | 19,874.3594 | 17,731 | 15.5 | black | 24.796875 | 38 | 0.800903 | 0.734985 | 4 | 1 | 0 | no | 0.8 | 0.8 | no dnr | 10 | 110 | 6.399414 | 116 | 46 | 39.19531 | 130 | null | 8.798828 | 1 | 129 | 7.439453 | 124 | 18 | 1,515 | 1 | 0 | no(M2 and SIP pres) | 0 |
4,300 | 51.19498 | 1 | male | 1 | 17 | 17 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 17 | under $11k | 0 | 110,430 | null | null | 36 | white | 33.59375 | 63 | 0.634888 | 0.532959 | 7 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 17 | 41 | 17.5 | 44 | 12 | 39 | 130 | 2.099609 | 2.599609 | 1.599854 | 145 | 7.429688 | 184 | 15 | 2,240 | null | null | <2 mo. follow-up | 2.17334 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.